About
Management team
Experienced team developing novel therapies for inherited retinal disorders
AAVantgarde is global biopharmaceutical company with operations in Italy and London. The team has a long track record of success in developing treatments for genetic therapies and inherited retinal disorders. The founder, Professor Alberto Auricchio, is a highly recognized scientist and a pioneer in large gene delivery.
Natalia Misciattelli PhD
Chief Executive Officer
Prof. Alberto Auricchio
Founder and Chief Science Officer
Dr. Jayashree Sahni
FRCOphth, EMBA, MD
Magda Blanco PhD, MBA
Head of Corporate Development
Nina Kotsopoulou PhD
Chief Technical Officer
Rasmus Holm-Jorgensen
Chief Financial Officer